ArticleBMJ open2023

Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis.

Hongbin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.